Csenge Advisory Group
- SEC CIK
- 0001715593
- Latest filing
- Aug 10, 2026
NVO holding history
Novo Nordisk A S in every 13F filed by Csenge Advisory Group, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVO overviewAll 13F holders of NVOFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 17
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −9,778−100.0% | Sold out | Holders |
| Q2 2025 | 9,778 | $699.1K | <0.1% | −278−2.8% | Reduced | Holders |
| Q1 2025 | 10,056 | $584.1K | <0.1% | −402−3.8% | Reduced | Holders |
| Q4 2024 | 10,458 | $899.6K | <0.1% | −17,649−62.8% | Reduced | Holders |
| Q3 2024 | 28,107 | $3.37M | 0.2% | +585+2.1% | Added | Holders |
| Q2 2024 | 27,522 | $3.93M | 0.2% | +4,254+18.3% | Added | Holders |
| Q1 2024 | 23,268 | $2.99M | 0.2% | +3,694+18.9% | Added | Holders |
| Q4 2023 | 19,574 | $2.02M | 0.1% | +9,817+100.6% | Added | Holders |
| Q3 2023 | 9,757 | $887.3K | 0.1% | +3,159+47.9% | AddedConverted for a 2-for-1 split | Holders |
| Q2 2023 | 3,299 | $533.9K | <0.1% | +1,231+59.5% | Added | Holders |
| Q1 2023 | 2,068 | $329.1K | <0.1% | −161−7.2% | Reduced | Holders |
| Q4 2022 | 2,229 | $301.7K | <0.1% | −313−12.3% | Reduced | Holders |
| Q3 2022 | 2,542 | $253.0K | <0.1% | +95+3.9% | Added | Holders |
| Q2 2022 | 2,447 | $273.0K | <0.1% | −19−0.8% | Reduced | Holders |
| Q1 2022 | 2,466 | $274.0K | <0.1% | +59+2.5% | Added | Holders |
| Q4 2021 | 2,407 | $203.0K | <0.1% | −163−6.3% | Reduced | Holders |
| Q3 2021 | 2,570 | $246.0K | <0.1% | +163+6.8% | Added | Holders |
| Q2 2021 | 2,407 | $203.0K | <0.1% | +2,407 | New | Holders |